Home / State Street and SPDR / SPDR SERIES TRUST / State Street SPDR S&P Pharmaceuticals ETF
State Street SPDR S&P Pharmaceuticals ETF
A series of SPDR SERIES TRUST
- Vote records
- 501year to 30 June 2026
- Against management
- 35.3%263 of 745 marked votes
- Say-on-pay support
- 60.2%for, of for + against + abstain
- Shareholder-proposal support
- 43.8%for, of for + against + abstain
State Street SPDR S&P Pharmaceuticals ETF is a series of SPDR SERIES TRUST. For the year to 30 June 2026 its registrant reported 501 vote records for the series; 35.3% of the votes marked for or against management went against management. It voted for 60.2% of say-on-pay items and for 43.8% of proposals from security holders.
Compared with its registrant and family
| year to 30 June 2026 | This series | Its registrant | State Street and SPDR | Median fund registrant |
|---|---|---|---|---|
| Against-management share | 35.3% | 28.8% | 16.9% | 6.2% |
| Say-on-pay support rate | 60.2% | 66.9% | 77.1% | 91.6% |
| Shareholder-proposal support rate | 43.8% | 43.6% | 50.4% | 27.5% |
Votes by category
foragainstabstain, withhold or otheramber tick: the portion cast against management
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 470 | 302 | 69 | 35.1% | |
| SECTION 14A SAY-ON-PAY VOTES | 93 | 51 | 33 | 36.6% | |
| AUDIT-RELATED | 92 | 60 | 32 | 34.8% | |
| SHAREHOLDER RIGHTS AND DEFENSES | 4 | 3 | 1 | 25.0% | |
| EXTRAORDINARY TRANSACTIONS | 4 | 4 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 14 | 11 | 3 | 21.4% | |
| COMPENSATION | 37 | 22 | 15 | 40.5% | |
| CORPORATE GOVERNANCE | 27 | 15 | 12 | 44.4% | |
| ENVIRONMENT OR CLIMATE | 2 | 0 | 2 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 2 | 0 | 2 | 0.0% | |
| OTHER SOCIAL ISSUES | 6 | 2 | 4 | 33.3% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|---|
| year to 30 June 2026 | 501 | 35.3% | 60.2% | 43.8% |
Questions
How often did State Street SPDR S&P Pharmaceuticals ETF vote against management?
35.3% of the votes its registrant marked for or against management in the year to 30 June 2026 (263 of 745).
How did State Street SPDR S&P Pharmaceuticals ETF vote on executive pay?
It voted for 50 of 83 say-on-pay items cast for, against or abstain (60.2%).
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other shareholders voted or what the outcome was.
Where does the data come from?
From the Form N-PX filed by SPDR SERIES TRUST, which lists the series that cast each vote. The SEC does not verify the contents. Data runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX filed by SPDR SERIES TRUST (filer no. 1064642); votes attributed to series S000012321 by the filer. Not verified by the SEC. Filings read through 23 Sep 2026.